speb/financial-data huggingface dataset:
PHYS.TO cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -82470000.00
PHYS.TO income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -82470000.00
PHYS.TO cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -804546000.00
PHYS.TO cash_flow (annual, 2022-12-31) — Net Other Financing Charges: 0.00
PHYS.TO balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 5746095000.00
PHYS.TO income_statement (annual, 2022-12-31) — Normalized Income: -82470000.00
PHYS.TO cash_flow (annual, 2022-12-31) — Operating Cash Flow: -22684000.00
PHYS.TO income_statement (annual, 2022-12-31) — Operating Revenue: -78930000.00
PHYS.TO balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 397346037.00
PHYS.TO balance_sheet (annual, 2022-12-31) — Other Equity Interest: -113679000.00
PHYS.TO income_statement (annual, 2022-12-31) — Other Operating Expenses: 1193000.00
PHYS.TO balance_sheet (annual, 2022-12-31) — Payables: 144000.00
PHYS.TO income_statement (annual, 2022-12-31) — Pretax Income: -82470000.00
PHYS.TO cash_flow (annual, 2022-12-31) — Purchase Of Investment: -806723000.00
PHYS.TO cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -185000.00
PHYS.TO balance_sheet (annual, 2022-12-31) — Retained Earnings: 606950000.00
PHYS.TO cash_flow (annual, 2022-12-31) — Sale Of Investment: 2177000.00
PHYS.TO income_statement (annual, 2022-12-31) — Selling General And Administration: 2347000.00
PHYS.TO balance_sheet (annual, 2022-12-31) — Share Issued: 397346037.00
PHYS.TO balance_sheet (annual, 2022-12-31) — Stockholders Equity: 5746095000.00
PHYS.TO balance_sheet (annual, 2022-12-31) — Tangible Book Value: 5746095000.00
PHYS.TO income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
PHYS.TO income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
PHYS.TO balance_sheet (annual, 2022-12-31) — Total Assets: 5746239000.00
PHYS.TO balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 5746095000.00
PHYS.TO balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 144000.00
PHYS.TO income_statement (annual, 2023-12-31) — +Operating Expense: 3720000.00
PHYS.TO income_statement (annual, 2023-12-31) — +Total Revenue: 727245000.00
PHYS.TO balance_sheet (annual, 2023-12-31) — Accounts Payable: 126000.00
PHYS.TO balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 142000.00
PHYS.TO balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 6506367000.00
PHYS.TO income_statement (annual, 2023-12-31) — Basic Average Shares: 400234773.00
PHYS.TO income_statement (annual, 2023-12-31) — Basic EPS: 1.81
PHYS.TO cash_flow (annual, 2023-12-31) — Beginning Cash Position: 294000.00
PHYS.TO balance_sheet (annual, 2023-12-31) — Capital Stock: 5378109000.00
PHYS.TO balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 25484000.00
PHYS.TO balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Federal Funds Sold: 25484000.00
PHYS.TO balance_sheet (annual, 2023-12-31) — Cash Financial: 25484000.00
PHYS.TO cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 0.00
PHYS.TO cash_flow (annual, 2023-12-31) — Change In Payable: -18000.00
PHYS.TO cash_flow (annual, 2023-12-31) — Change In Working Capital: -18000.00
PHYS.TO cash_flow (annual, 2023-12-31) — Changes In Cash: 25190000.00
PHYS.TO balance_sheet (annual, 2023-12-31) — Common Stock: 5378109000.00
PHYS.TO balance_sheet (annual, 2023-12-31) — Common Stock Equity: 6531725000.00
PHYS.TO cash_flow (annual, 2023-12-31) — Common Stock Issuance: 243051000.00
PHYS.TO cash_flow (annual, 2023-12-31) — Common Stock Payments: -3859000.00
PHYS.TO income_statement (annual, 2023-12-31) — Diluted Average Shares: 400234773.00
PHYS.TO income_statement (annual, 2023-12-31) — Diluted EPS: 1.81
PHYS.TO income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 723525000.00
PHYS.TO cash_flow (annual, 2023-12-31) — End Cash Position: 25484000.00
PHYS.TO balance_sheet (annual, 2023-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 6506367000.00
PHYS.TO cash_flow (annual, 2023-12-31) — Financing Cash Flow: 238607000.00
PHYS.TO cash_flow (annual, 2023-12-31) — Free Cash Flow: -24568000.00
PHYS.TO cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -748075000.00
PHYS.TO income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 36901000.00
PHYS.TO income_statement (annual, 2023-12-31) — General And Administrative Expense: 2355000.00
PHYS.TO cash_flow (annual, 2023-12-31) — Investing Cash Flow: -188849000.00
PHYS.TO balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 6506367000.00
PHYS.TO balance_sheet (annual, 2023-12-31) — Investments And Advances: 6506367000.00
PHYS.TO cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 243051000.00
PHYS.TO cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 239192000.00
PHYS.TO income_statement (annual, 2023-12-31) — Net Income: 723525000.00
PHYS.TO income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 723525000.00
PHYS.TO income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 723525000.00
PHYS.TO income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 723525000.00
PHYS.TO income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 723525000.00
PHYS.TO cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 723525000.00
PHYS.TO income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 723525000.00
PHYS.TO cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -188849000.00
PHYS.TO cash_flow (annual, 2023-12-31) — Net Other Financing Charges: 0.00
PHYS.TO balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 6531725000.00
PHYS.TO income_statement (annual, 2023-12-31) — Normalized Income: 723525000.00
PHYS.TO cash_flow (annual, 2023-12-31) — Operating Cash Flow: -24568000.00
PHYS.TO income_statement (annual, 2023-12-31) — Operating Revenue: 727245000.00
PHYS.TO balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 401306562.00
PHYS.TO balance_sheet (annual, 2023-12-31) — Other Equity Interest: -114264000.00
PHYS.TO income_statement (annual, 2023-12-31) — Other Operating Expenses: 1365000.00
PHYS.TO balance_sheet (annual, 2023-12-31) — Payables: 126000.00
PHYS.TO income_statement (annual, 2023-12-31) — Pretax Income: 723525000.00
PHYS.TO cash_flow (annual, 2023-12-31) — Purchase Of Investment: -198628000.00
PHYS.TO cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -3859000.00
PHYS.TO balance_sheet (annual, 2023-12-31) — Retained Earnings: 1267738000.00
PHYS.TO cash_flow (annual, 2023-12-31) — Sale Of Investment: 9779000.00
PHYS.TO income_statement (annual, 2023-12-31) — Selling General And Administration: 2355000.00
PHYS.TO balance_sheet (annual, 2023-12-31) — Share Issued: 401306562.00
PHYS.TO balance_sheet (annual, 2023-12-31) — Stockholders Equity: 6531725000.00
PHYS.TO balance_sheet (annual, 2023-12-31) — Tangible Book Value: 6531725000.00
PHYS.TO income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
PHYS.TO income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.40
PHYS.TO balance_sheet (annual, 2023-12-31) — Total Assets: 6531851000.00
PHYS.TO balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 6531725000.00
PHYS.TO balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 126000.00
PHYS.TO income_statement (quarterly, 2024-09-30) — Basic Average Shares: 407295768.00
PHYS.TO income_statement (quarterly, 2024-09-30) — Basic EPS: 2.39
PHYS.TO cash_flow (quarterly, 2024-09-30) — Change In Other Current Assets: -41000.00
PHYS.TO cash_flow (quarterly, 2024-09-30) — Common Stock Payments: 0.00
PHYS.TO income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 407295768.00
PHYS.TO income_statement (quarterly, 2024-09-30) — Diluted EPS: 2.39
PHYS.TO balance_sheet (quarterly, 2024-09-30) — Other Payable: 21228000.00
PHYS.TO cash_flow (quarterly, 2024-09-30) — Repurchase Of Capital Stock: 0.00
PHYS.TO cash_flow (quarterly, 2024-09-30) — Sale Of Investment: 0.00
PHYS.TO income_statement (annual, 2024-12-31) — +Operating Expense: 4448000.00
PHYS.TO income_statement (annual, 2024-12-31) — +Total Revenue: 1732642000.00
PHYS.TO balance_sheet (annual, 2024-12-31) — Accounts Payable: 3033000.00
PHYS.TO balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 145000.00
PHYS.TO income_statement (annual, 2024-12-31) — Basic Average Shares: 405188238.00
PHYS.TO income_statement (annual, 2024-12-31) — Basic EPS: 4.27
PHYS.TO cash_flow (annual, 2024-12-31) — Beginning Cash Position: 25484000.00
PHYS.TO balance_sheet (annual, 2024-12-31) — Capital Stock: 5815259000.00
PHYS.TO balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 8924000.00
PHYS.TO balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Federal Funds Sold: 8924000.00
PHYS.TO balance_sheet (annual, 2024-12-31) — Cash Financial: 8924000.00
PHYS.TO cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: 0.00
PHYS.TO cash_flow (annual, 2024-12-31) — Change In Payable: 2907000.00
PHYS.TO cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 0.00
PHYS.TO cash_flow (annual, 2024-12-31) — Change In Working Capital: 2907000.00
PHYS.TO cash_flow (annual, 2024-12-31) — Changes In Cash: -16560000.00
PHYS.TO balance_sheet (annual, 2024-12-31) — Common Stock: 5815259000.00
PHYS.TO balance_sheet (annual, 2024-12-31) — Common Stock Equity: 8608197000.00
PHYS.TO cash_flow (annual, 2024-12-31) — Common Stock Issuance: 564199000.00
PHYS.TO cash_flow (annual, 2024-12-31) — Common Stock Payments: -3504000.00
PHYS.TO cash_flow (quarterly, 2024-12-31) — Common Stock Payments: -747000.00
PHYS.TO income_statement (annual, 2024-12-31) — Diluted Average Shares: 405188238.00
PHYS.TO income_statement (annual, 2024-12-31) — Diluted EPS: 4.27
PHYS.TO income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 1728194000.00
PHYS.TO cash_flow (annual, 2024-12-31) — End Cash Position: 8924000.00
PHYS.TO balance_sheet (annual, 2024-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 8602306000.00
PHYS.TO cash_flow (annual, 2024-12-31) — Financing Cash Flow: 559841000.00
PHYS.TO cash_flow (annual, 2024-12-31) — Free Cash Flow: -27316000.00
PHYS.TO cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: -1758417000.00
PHYS.TO income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 57138000.00
PHYS.TO income_statement (annual, 2024-12-31) — General And Administrative Expense: 2793000.00
PHYS.TO cash_flow (annual, 2024-12-31) — Investing Cash Flow: -549085000.00
PHYS.TO balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 8602306000.00
PHYS.TO balance_sheet (annual, 2024-12-31) — Investments And Advances: 8602306000.00
PHYS.TO cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 564199000.00
PHYS.TO cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 560695000.00
PHYS.TO income_statement (annual, 2024-12-31) — Net Income: 1728194000.00
PHYS.TO income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 1728194000.00
PHYS.TO income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 1728194000.00
PHYS.TO income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 1728194000.00
PHYS.TO income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 1728194000.00
PHYS.TO cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 1728194000.00
PHYS.TO income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 1728194000.00
PHYS.TO cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -549085000.00
PHYS.TO cash_flow (annual, 2024-12-31) — Net Other Financing Charges: 0.00
PHYS.TO balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 8608197000.00
PHYS.TO income_statement (annual, 2024-12-31) — Normalized Income: 1728194000.00
PHYS.TO cash_flow (annual, 2024-12-31) — Operating Cash Flow: -27316000.00
PHYS.TO income_statement (annual, 2024-12-31) — Operating Revenue: 1732642000.00
PHYS.TO balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 418098502.00
PHYS.TO balance_sheet (annual, 2024-12-31) — Other Equity Interest: -115118000.00
PHYS.TO income_statement (annual, 2024-12-31) — Other Operating Expenses: 1655000.00
PHYS.TO balance_sheet (annual, 2024-12-31) — Payables: 3033000.00
PHYS.TO balance_sheet (annual, 2024-12-31) — Prepaid Assets: 0.00
PHYS.TO balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 0.00
PHYS.TO income_statement (annual, 2024-12-31) — Pretax Income: 1728194000.00
PHYS.TO cash_flow (annual, 2024-12-31) — Purchase Of Investment: -549085000.00
PHYS.TO cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -3504000.00
PHYS.TO cash_flow (quarterly, 2024-12-31) — Repurchase Of Capital Stock: -747000.00
PHYS.TO balance_sheet (annual, 2024-12-31) — Retained Earnings: 2907911000.00
PHYS.TO cash_flow (annual, 2024-12-31) — Sale Of Investment: 0.00
PHYS.TO cash_flow (quarterly, 2024-12-31) — Sale Of Investment: 0.00
PHYS.TO income_statement (annual, 2024-12-31) — Selling General And Administration: 2793000.00
PHYS.TO balance_sheet (annual, 2024-12-31) — Share Issued: 418098502.00
PHYS.TO balance_sheet (annual, 2024-12-31) — Stockholders Equity: 8608197000.00
PHYS.TO balance_sheet (annual, 2024-12-31) — Tangible Book Value: 8608197000.00
PHYS.TO income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
PHYS.TO income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.15
PHYS.TO balance_sheet (annual, 2024-12-31) — Total Assets: 8611230000.00
PHYS.TO balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 8608197000.00
PHYS.TO balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 3033000.00
PHYS.TO income_statement (quarterly, 2025-03-31) — +Operating Expense: 1178000.00
PHYS.TO income_statement (quarterly, 2025-03-31) — +Total Revenue: 1649973000.00
PHYS.TO balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 0.00
PHYS.TO balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 145000.00
PHYS.TO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 424319504.00
PHYS.TO income_statement (quarterly, 2025-03-31) — Basic EPS: 3.89
PHYS.TO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 8924000.00
PHYS.TO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 6291400000.00
PHYS.TO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 28823000.00
PHYS.TO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Federal Funds Sold: 28823000.00
PHYS.TO balance_sheet (quarterly, 2025-03-31) — Cash Financial: 28823000.00
PHYS.TO cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: -530000.00
PHYS.TO cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: 0.00
PHYS.TO cash_flow (quarterly, 2025-03-31) — Change In Payable: 9284000.00
PHYS.TO cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 0.00
PHYS.TO cash_flow (quarterly, 2025-03-31) — Change In Receivables: -56556000.00
PHYS.TO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -47802000.00
PHYS.TO cash_flow (quarterly, 2025-03-31) — Changes In Cash: 19899000.00
PHYS.TO balance_sheet (quarterly, 2025-03-31) — Common Stock: 6291400000.00
PHYS.TO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 10731690000.00
PHYS.TO cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 476720000.00
PHYS.TO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 424319504.00
PHYS.TO income_statement (quarterly, 2025-03-31) — Diluted EPS: 3.89
PHYS.TO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 1648795000.00
PHYS.TO cash_flow (quarterly, 2025-03-31) — End Cash Position: 28823000.00
PHYS.TO balance_sheet (quarterly, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 10658098000.00
PHYS.TO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 475907000.00
PHYS.TO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -56979000.00
PHYS.TO cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -1657972000.00
PHYS.TO income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 503000.00
PHYS.TO income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 685000.00
PHYS.TO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -399029000.00
PHYS.TO balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 10658098000.00
PHYS.TO balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 10658098000.00
PHYS.TO cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 476720000.00
PHYS.TO cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 476720000.00
PHYS.TO income_statement (quarterly, 2025-03-31) — Net Income: 1648795000.00
PHYS.TO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 1648795000.00
PHYS.TO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 1648795000.00
PHYS.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 1648795000.00
PHYS.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 1648795000.00
PHYS.TO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 1648795000.00
PHYS.TO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 1648795000.00
PHYS.TO cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -399029000.00
PHYS.TO cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: 0.00
PHYS.TO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 10731690000.00
PHYS.TO income_statement (quarterly, 2025-03-31) — Normalized Income: 1648795000.00
PHYS.TO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -56979000.00
PHYS.TO income_statement (quarterly, 2025-03-31) — Operating Revenue: 1649973000.00
PHYS.TO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 438873163.00
PHYS.TO balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: -115931000.00
PHYS.TO income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 493000.00
PHYS.TO balance_sheet (quarterly, 2025-03-31) — Other Payable: 12317000.00
PHYS.TO balance_sheet (quarterly, 2025-03-31) — Payables: 12317000.00
PHYS.TO income_statement (quarterly, 2025-03-31) — Pretax Income: 1648795000.00
PHYS.TO cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -399029000.00
PHYS.TO balance_sheet (quarterly, 2025-03-31) — Receivables: 56556000.00
PHYS.TO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 4556076000.00
PHYS.TO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 685000.00
PHYS.TO balance_sheet (quarterly, 2025-03-31) — Share Issued: 438873163.00
PHYS.TO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 10731690000.00
PHYS.TO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 10731690000.00
PHYS.TO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
PHYS.TO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.15
PHYS.TO balance_sheet (quarterly, 2025-03-31) — Total Assets: 10744007000.00
PHYS.TO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 10731690000.00
PHYS.TO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 12317000.00
PHYS.TO income_statement (quarterly, 2025-06-30) — +Operating Expense: 1135000.00
PHYS.TO income_statement (quarterly, 2025-06-30) — +Total Revenue: 620132000.00
PHYS.TO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 303000.00
PHYS.TO balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 145000.00
PHYS.TO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 461781131.00
PHYS.TO income_statement (quarterly, 2025-06-30) — Basic EPS: 1.34
PHYS.TO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 28823000.00
PHYS.TO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 6949237000.00
PHYS.TO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 30063000.00
PHYS.TO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Federal Funds Sold: 30063000.00
PHYS.TO balance_sheet (quarterly, 2025-06-30) — Cash Financial: 30063000.00
PHYS.TO cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 530000.00
PHYS.TO cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: 0.00
PHYS.TO cash_flow (quarterly, 2025-06-30) — Change In Payable: -12014000.00
PHYS.TO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 45072000.00
PHYS.TO cash_flow (quarterly, 2025-06-30) — Changes In Cash: 1240000.00
PHYS.TO balance_sheet (quarterly, 2025-06-30) — Common Stock: 6949237000.00
PHYS.TO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 11962886000.00
PHYS.TO cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 684545000.00
PHYS.TO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 461781131.00
PHYS.TO income_statement (quarterly, 2025-06-30) — Diluted EPS: 1.34
PHYS.TO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 618997000.00
PHYS.TO cash_flow (quarterly, 2025-06-30) — End Cash Position: 30063000.00
PHYS.TO balance_sheet (quarterly, 2025-06-30) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 11933126000.00
PHYS.TO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 679751000.00
PHYS.TO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 34403000.00
PHYS.TO cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -629666000.00
PHYS.TO income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 31248000.00
PHYS.TO income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 691000.00
PHYS.TO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -712914000.00
PHYS.TO balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 11933126000.00
PHYS.TO balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 11933126000.00
PHYS.TO cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 684545000.00
PHYS.TO cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 683444000.00
PHYS.TO income_statement (quarterly, 2025-06-30) — Net Income: 618997000.00
PHYS.TO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 618997000.00
PHYS.TO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 618997000.00
PHYS.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 618997000.00
PHYS.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 618997000.00
PHYS.TO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 618997000.00
PHYS.TO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 618997000.00
PHYS.TO cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -712914000.00
PHYS.TO cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: 0.00
PHYS.TO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 11962886000.00
PHYS.TO income_statement (quarterly, 2025-06-30) — Normalized Income: 618997000.00
PHYS.TO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 34403000.00
PHYS.TO income_statement (quarterly, 2025-06-30) — Operating Revenue: 620132000.00
PHYS.TO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 464070286.00
PHYS.TO balance_sheet (quarterly, 2025-06-30) — Other Equity Interest: -119624000.00
PHYS.TO income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 444000.00
PHYS.TO balance_sheet (quarterly, 2025-06-30) — Payables: 303000.00
PHYS.TO income_statement (quarterly, 2025-06-30) — Pretax Income: 618997000.00
PHYS.TO cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -712914000.00
PHYS.TO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 5133128000.00
PHYS.TO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 691000.00
PHYS.TO balance_sheet (quarterly, 2025-06-30) — Share Issued: 464070286.00
PHYS.TO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 11962886000.00
PHYS.TO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 11962886000.00
PHYS.TO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
PHYS.TO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.15
PHYS.TO balance_sheet (quarterly, 2025-06-30) — Total Assets: 11963189000.00
PHYS.TO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 11962886000.00
PHYS.TO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 303000.00
PHYS.TO income_statement (quarterly, 2025-09-30) — +Operating Expense: 1525000.00
PHYS.TO income_statement (quarterly, 2025-09-30) — +Total Revenue: 2004822000.00
PHYS.TO balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 3418000.00
PHYS.TO balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 145000.00
PHYS.TO income_statement (quarterly, 2025-09-30) — Basic Average Shares: 465446326.00
PHYS.TO income_statement (quarterly, 2025-09-30) — Basic EPS: 4.30
PHYS.TO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 30063000.00
PHYS.TO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 7095168000.00
PHYS.TO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 26046000.00
PHYS.TO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Federal Funds Sold: 26046000.00
PHYS.TO balance_sheet (quarterly, 2025-09-30) — Cash Financial: 26046000.00
PHYS.TO cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 0.00
PHYS.TO cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: 0.00
PHYS.TO cash_flow (quarterly, 2025-09-30) — Change In Payable: 3115000.00
PHYS.TO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -13732000.00
PHYS.TO cash_flow (quarterly, 2025-09-30) — Changes In Cash: -4017000.00
PHYS.TO balance_sheet (quarterly, 2025-09-30) — Common Stock: 7095168000.00
PHYS.TO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 14111913000.00
PHYS.TO cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 145931000.00
PHYS.TO cash_flow (quarterly, 2025-09-30) — Common Stock Payments: 0.00
PHYS.TO income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 465446326.00
PHYS.TO income_statement (quarterly, 2025-09-30) — Diluted EPS: 4.30
PHYS.TO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 2003297000.00
PHYS.TO cash_flow (quarterly, 2025-09-30) — End Cash Position: 26046000.00
PHYS.TO balance_sheet (quarterly, 2025-09-30) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 14072438000.00
PHYS.TO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 145730000.00
PHYS.TO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -25966000.00
PHYS.TO cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -2015531000.00
PHYS.TO income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 0.00
PHYS.TO income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 862000.00
PHYS.TO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -123781000.00
PHYS.TO balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 14072438000.00
PHYS.TO balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 14072438000.00
PHYS.TO cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 145931000.00
PHYS.TO cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 145931000.00
PHYS.TO income_statement (quarterly, 2025-09-30) — Net Income: 2003297000.00
PHYS.TO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 2003297000.00
PHYS.TO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 2003297000.00
PHYS.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 2003297000.00
PHYS.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 2003297000.00
PHYS.TO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 2003297000.00
PHYS.TO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 2003297000.00
PHYS.TO cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -123781000.00
PHYS.TO cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 0.00
PHYS.TO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 14111913000.00
PHYS.TO income_statement (quarterly, 2025-09-30) — Normalized Income: 2003297000.00
PHYS.TO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -25966000.00
PHYS.TO income_statement (quarterly, 2025-09-30) — Operating Revenue: 2004822000.00
PHYS.TO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 469355137.00
PHYS.TO balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: -119825000.00
PHYS.TO income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 663000.00
PHYS.TO balance_sheet (quarterly, 2025-09-30) — Payables: 3418000.00
PHYS.TO income_statement (quarterly, 2025-09-30) — Pretax Income: 2003297000.00
PHYS.TO cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -123781000.00
PHYS.TO balance_sheet (quarterly, 2025-09-30) — Receivables: 16847000.00
PHYS.TO cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: 0.00
PHYS.TO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 7136425000.00
PHYS.TO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 862000.00
PHYS.TO balance_sheet (quarterly, 2025-09-30) — Share Issued: 469355137.00
PHYS.TO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 14111913000.00
PHYS.TO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 14111913000.00
PHYS.TO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
PHYS.TO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.15
PHYS.TO balance_sheet (quarterly, 2025-09-30) — Total Assets: 14115331000.00
PHYS.TO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 14111913000.00
PHYS.TO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 3418000.00
PHYS.TO income_statement (annual, 2025-12-31) — +Operating Expense: 6771000.00
PHYS.TO income_statement (quarterly, 2025-12-31) — +Operating Expense: 2933000.00
PHYS.TO income_statement (annual, 2025-12-31) — +Total Revenue: 5955378000.00
PHYS.TO income_statement (quarterly, 2025-12-31) — +Total Revenue: 1680451000.00
PHYS.TO balance_sheet (annual, 2025-12-31) — Accounts Payable: 3305000.00
PHYS.TO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 3305000.00
PHYS.TO balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 146000.00
PHYS.TO balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 146000.00
PHYS.TO income_statement (annual, 2025-12-31) — Basic Average Shares: 457313977.00
PHYS.TO income_statement (annual, 2025-12-31) — Basic EPS: 13.01
PHYS.TO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 8924000.00
PHYS.TO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 26046000.00
PHYS.TO balance_sheet (annual, 2025-12-31) — Capital Stock: 7427746000.00
PHYS.TO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 7427746000.00
PHYS.TO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 26912000.00
PHYS.TO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 26912000.00
PHYS.TO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 26912000.00
PHYS.TO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 26912000.00
PHYS.TO balance_sheet (annual, 2025-12-31) — Cash Financial: 26912000.00
PHYS.TO balance_sheet (quarterly, 2025-12-31) — Cash Financial: 26912000.00
PHYS.TO cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 0.00
PHYS.TO cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 0.00
PHYS.TO cash_flow (annual, 2025-12-31) — Change In Payable: 272000.00
PHYS.TO cash_flow (quarterly, 2025-12-31) — Change In Payable: -113000.00
PHYS.TO cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -154000.00
PHYS.TO cash_flow (annual, 2025-12-31) — Change In Working Capital: 118000.00
PHYS.TO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 16580000.00
PHYS.TO cash_flow (annual, 2025-12-31) — Changes In Cash: 17988000.00
PHYS.TO cash_flow (quarterly, 2025-12-31) — Changes In Cash: 866000.00
PHYS.TO balance_sheet (annual, 2025-12-31) — Common Stock: 7427746000.00
PHYS.TO balance_sheet (quarterly, 2025-12-31) — Common Stock: 7427746000.00
PHYS.TO balance_sheet (annual, 2025-12-31) — Common Stock Equity: 15976483000.00
PHYS.TO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 15976483000.00
PHYS.TO cash_flow (annual, 2025-12-31) — Common Stock Issuance: 1702893000.00
PHYS.TO cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 395697000.00
PHYS.TO cash_flow (annual, 2025-12-31) — Common Stock Payments: -4632000.00
PHYS.TO cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -3531000.00
PHYS.TO income_statement (annual, 2025-12-31) — Diluted Average Shares: 457313977.00
PHYS.TO income_statement (annual, 2025-12-31) — Diluted EPS: 13.01
PHYS.TO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 5948607000.00
PHYS.TO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 1677518000.00
PHYS.TO cash_flow (annual, 2025-12-31) — End Cash Position: 26912000.00
PHYS.TO cash_flow (quarterly, 2025-12-31) — End Cash Position: 26912000.00
PHYS.TO balance_sheet (annual, 2025-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 15952722000.00
PHYS.TO balance_sheet (quarterly, 2025-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 15952722000.00
PHYS.TO cash_flow (annual, 2025-12-31) — Financing Cash Flow: 1693149000.00
PHYS.TO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 391761000.00
PHYS.TO cash_flow (annual, 2025-12-31) — Free Cash Flow: -48192000.00
PHYS.TO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 350000.00
PHYS.TO cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -5996917000.00
PHYS.TO cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -1693748000.00
PHYS.TO income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 147583000.00
PHYS.TO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 115832000.00
PHYS.TO income_statement (annual, 2025-12-31) — General And Administrative Expense: 4096000.00
PHYS.TO income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 1858000.00
PHYS.TO cash_flow (annual, 2025-12-31) — Investing Cash Flow: -1626969000.00
PHYS.TO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -391245000.00
PHYS.TO balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 15952722000.00
PHYS.TO balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 15952722000.00
PHYS.TO balance_sheet (annual, 2025-12-31) — Investments And Advances: 15952722000.00
PHYS.TO balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 15952722000.00
PHYS.TO cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 1702893000.00
PHYS.TO cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 395697000.00
PHYS.TO cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 1698261000.00
PHYS.TO cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 392166000.00
PHYS.TO income_statement (annual, 2025-12-31) — Net Income: 5948607000.00
PHYS.TO income_statement (quarterly, 2025-12-31) — Net Income: 1677518000.00
PHYS.TO income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 5948607000.00
PHYS.TO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 1677518000.00
PHYS.TO income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 5948607000.00
PHYS.TO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 1677518000.00
PHYS.TO income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 5948607000.00
PHYS.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 1677518000.00
PHYS.TO income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 5948607000.00
PHYS.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 1677518000.00
PHYS.TO cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 5948607000.00
PHYS.TO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 1677518000.00
PHYS.TO income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 5948607000.00
PHYS.TO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 1677518000.00
PHYS.TO cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -1626969000.00
PHYS.TO cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -391245000.00
PHYS.TO cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 0.00
PHYS.TO cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 0.00
PHYS.TO balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 15976483000.00
PHYS.TO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 15976483000.00
PHYS.TO income_statement (annual, 2025-12-31) — Normalized Income: 5948607000.00
PHYS.TO income_statement (quarterly, 2025-12-31) — Normalized Income: 1677518000.00
PHYS.TO cash_flow (annual, 2025-12-31) — Operating Cash Flow: -48192000.00
PHYS.TO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 350000.00
PHYS.TO income_statement (annual, 2025-12-31) — Operating Revenue: 5955378000.00
PHYS.TO income_statement (quarterly, 2025-12-31) — Operating Revenue: 1680451000.00
PHYS.TO balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 475484857.00
PHYS.TO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 475484857.00
PHYS.TO balance_sheet (annual, 2025-12-31) — Other Equity Interest: -120230000.00
PHYS.TO balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: -120230000.00
PHYS.TO income_statement (annual, 2025-12-31) — Other Operating Expenses: 2675000.00
PHYS.TO income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 1075000.00
PHYS.TO balance_sheet (annual, 2025-12-31) — Payables: 3305000.00
PHYS.TO balance_sheet (quarterly, 2025-12-31) — Payables: 3305000.00
PHYS.TO balance_sheet (annual, 2025-12-31) — Prepaid Assets: 154000.00
PHYS.TO balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 154000.00
PHYS.TO income_statement (annual, 2025-12-31) — Pretax Income: 5948607000.00
PHYS.TO income_statement (quarterly, 2025-12-31) — Pretax Income: 1677518000.00
PHYS.TO cash_flow (annual, 2025-12-31) — Purchase Of Investment: -1626969000.00
PHYS.TO cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -391245000.00
PHYS.TO cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -4632000.00
PHYS.TO cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -3531000.00
PHYS.TO balance_sheet (annual, 2025-12-31) — Retained Earnings: 8668821000.00
PHYS.TO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 8668821000.00
PHYS.TO income_statement (annual, 2025-12-31) — Selling General And Administration: 4096000.00
PHYS.TO income_statement (quarterly, 2025-12-31) — Selling General And Administration: 1858000.00
PHYS.TO balance_sheet (annual, 2025-12-31) — Share Issued: 475484857.00
PHYS.TO balance_sheet (quarterly, 2025-12-31) — Share Issued: 475484857.00
PHYS.TO balance_sheet (annual, 2025-12-31) — Stockholders Equity: 15976483000.00
PHYS.TO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 15976483000.00
PHYS.TO balance_sheet (annual, 2025-12-31) — Tangible Book Value: 15976483000.00
PHYS.TO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 15976483000.00
PHYS.TO income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
PHYS.TO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
PHYS.TO income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.15
PHYS.TO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.15
PHYS.TO balance_sheet (annual, 2025-12-31) — Total Assets: 15979788000.00
PHYS.TO balance_sheet (quarterly, 2025-12-31) — Total Assets: 15979788000.00
PHYS.TO balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 15976483000.00
PHYS.TO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 15976483000.00
PHYS.TO balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 3305000.00
PHYS.TO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 3305000.00
PHYS.TO income_statement (quarterly, 2026-03-31) — +Operating Expense: 1748000.00
PHYS.TO income_statement (quarterly, 2026-03-31) — +Total Revenue: 1312295000.00
PHYS.TO balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 6289000.00
PHYS.TO balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 146000.00
PHYS.TO income_statement (quarterly, 2026-03-31) — Basic Average Shares: 481765255.00
PHYS.TO income_statement (quarterly, 2026-03-31) — Basic EPS: 2.72
PHYS.TO cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 26912000.00
PHYS.TO balance_sheet (quarterly, 2026-03-31) — Capital Stock: 7806907000.00
PHYS.TO balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 51368000.00
PHYS.TO balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Federal Funds Sold: 51368000.00
PHYS.TO balance_sheet (quarterly, 2026-03-31) — Cash Financial: 51368000.00
PHYS.TO cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 0.00
PHYS.TO cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: 0.00
PHYS.TO cash_flow (quarterly, 2026-03-31) — Change In Payable: 2984000.00
PHYS.TO cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 154000.00
PHYS.TO cash_flow (quarterly, 2026-03-31) — Change In Receivables: -12653000.00
PHYS.TO cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -9515000.00
PHYS.TO cash_flow (quarterly, 2026-03-31) — Changes In Cash: 24456000.00
PHYS.TO balance_sheet (quarterly, 2026-03-31) — Common Stock: 7806907000.00
PHYS.TO balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 17275584000.00
PHYS.TO cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 504646000.00
PHYS.TO cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -7602000.00
PHYS.TO income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 481765255.00
PHYS.TO income_statement (quarterly, 2026-03-31) — Diluted EPS: 2.72
PHYS.TO income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 1310547000.00
PHYS.TO cash_flow (quarterly, 2026-03-31) — End Cash Position: 51368000.00
PHYS.TO balance_sheet (quarterly, 2026-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 17217852000.00
PHYS.TO cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 495310000.00
PHYS.TO cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -26383000.00
PHYS.TO cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: -1327415000.00
PHYS.TO income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 322682000.00
PHYS.TO income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 805000.00
PHYS.TO cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -444471000.00
PHYS.TO balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 17217852000.00
PHYS.TO balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 17217852000.00
PHYS.TO cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 504646000.00
PHYS.TO cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 497044000.00
PHYS.TO income_statement (quarterly, 2026-03-31) — Net Income: 1310547000.00
PHYS.TO income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 1310547000.00
PHYS.TO income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 1310547000.00
PHYS.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 1310547000.00
PHYS.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 1310547000.00
PHYS.TO cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 1310547000.00
PHYS.TO income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 1310547000.00
PHYS.TO cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -444471000.00
PHYS.TO cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: 0.00
PHYS.TO balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 17275584000.00
PHYS.TO income_statement (quarterly, 2026-03-31) — Normalized Income: 1310547000.00
PHYS.TO cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -26383000.00
PHYS.TO income_statement (quarterly, 2026-03-31) — Operating Revenue: 1312295000.00
PHYS.TO balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 476682504.00
PHYS.TO balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: -121964000.00
PHYS.TO income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 943000.00
PHYS.TO balance_sheet (quarterly, 2026-03-31) — Payables: 6289000.00
PHYS.TO balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 0.00
PHYS.TO income_statement (quarterly, 2026-03-31) — Pretax Income: 1310547000.00
PHYS.TO cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -444471000.00
PHYS.TO balance_sheet (quarterly, 2026-03-31) — Receivables: 12653000.00
PHYS.TO cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -7602000.00
PHYS.TO balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 9590495000.00
PHYS.TO income_statement (quarterly, 2026-03-31) — Selling General And Administration: 805000.00
PHYS.TO balance_sheet (quarterly, 2026-03-31) — Share Issued: 476682504.00
PHYS.TO balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 17275584000.00
PHYS.TO balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 17275584000.00
PHYS.TO income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
PHYS.TO income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
PHYS.TO balance_sheet (quarterly, 2026-03-31) — Total Assets: 17281873000.00
PHYS.TO balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 17275584000.00
PHYS.TO balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 6289000.00
PI balance_sheet (annual, 2021-12-31) — Current Debt: 9633000.00
PI cash_flow (annual, 2021-12-31) — Depreciation: 4602000.00
PI cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of PPE: 0.00
PI balance_sheet (annual, 2021-12-31) — Long Term Debt: 278661000.00
PI balance_sheet (annual, 2021-12-31) — Other Current Borrowings: 9633000.00
PI balance_sheet (annual, 2021-12-31) — Other Current Liabilities: 591000.00
PI balance_sheet (annual, 2021-12-31) — Other Non Current Liabilities: 279000.00
PI balance_sheet (annual, 2021-12-31) — Prepaid Assets: 5049000.00
PI income_statement (annual, 2022-12-31) — +Operating Expense: 157465000.00
PI income_statement (annual, 2022-12-31) — +Total Revenue: 257800000.00
PI balance_sheet (annual, 2022-12-31) — Accounts Payable: 25024000.00
PI balance_sheet (annual, 2022-12-31) — Accounts Receivable: 49996000.00
PI balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -27583000.00
PI balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 403599000.00
PI balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -755000.00
PI income_statement (annual, 2022-12-31) — Amortization: 0.00
PI income_statement (annual, 2022-12-31) — Amortization Of Intangibles Income Statement: 0.00
PI cash_flow (annual, 2022-12-31) — Amortization Of Securities: -233000.00